MedPath

Research on the effect of cacao product intake on postprandial hyperglycemia.

Not Applicable
Conditions
Healthy adult
Registration Number
JPRN-UMIN000032750
Lead Sponsor
The University of Shizuoka
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1) Subjects who are under treatment for chronic disorders 2) Subjects whose HbA1c level is greater than 6.5% at the second screening 3) Subjects whose blood glucose level is greater than 126 mg/dl when fasting at the second screening 4) Subjects who are allergic to chocolate, milk, soybeans, wheat, beef, chicken, pork, salmon, crab, banana, apples, and oranges 5) Subjects with headache induced by intake of chocolates 6) Subjects who highly intake cacao products on a daily basis (high cacao chocolate: 70 g or more/ week, milk chocolate :140 g or more/ week) 7) Subjects taking medicines (such as hypoglycemic drugs) with function claims that potentially influence the outcome of this study on a daily basis, or those who intend to take these during this study 8) Subjects whose sexual cycle is unstable (persons with sex cycle other than 28 days) 9) Subjects who have participated in other clinical and monitoring studies within 1 month before screening or who plan to participate in other clinical trials after this clinical trial consent 10) Subjects who are pregnant, or plan to get pregnant during the study period 11) Subjects who are breast-feeding 12) Alcohol-heavy drinkers (drinkers with an average daily of over 60 g in terms of pure alcohol) 13) Subjects who are judged as ineligible by the examination director and doctors

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath